Biome Australia Limited
Biome Australia Limited
- P/E ratio
- 21.74
Your view on BIO.AX
Overview
What the company does, where it operates, and who runs it.
About Biome Australia Limited
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Blair William Brabin Vega Norfolk
- Headquarters
- 192-194 Johnston Street, Collingwood, VIC, AU
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Blair William Brabin Vega Norfolk
- Headquarters
- 192-194 Johnston Street, Collingwood, VIC, AU
Biome Australia Limited, founded in 2018 and headquartered in Cremorne, Australia, specializes in the development, commercialization, and global distribution of live biotherapeutic and complementary health products.
The company's product line features live biotherapeutics under the Activated Probiotics brand, organic nutritional supplements branded as Activated Nutrients, and athletic performance and recovery items named Activated X Performance. These offerings are accessible to consumers through both community pharmacies and independent health practitioners.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Biome Australia Limited from FRC's valuation model, read against the market price. BIO.AX last traded at AUD 0.29, 21.7× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Biome Australia Limited. Starting points for Biome Australia Limited: P/E 21.7, EPS AUD 0.02, beta 0.97 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Biome Australia Limited. Biome Australia Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Biome Australia Limited. Trailing twelve-month EPS for Biome Australia Limited stands at AUD 0.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterDec 2026 | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|---|
| Average estimate | AUD 0.00 | AUD 0.02 | AUD 0.02 |
| Lowest estimate | AUD 0.00 | AUD 0.02 | AUD 0.02 |
| Highest estimate | AUD 0.00 | AUD 0.02 | AUD 0.02 |
| Number of analysts | 0 | 1 | 1 |
| A year ago | AUD 0.00 | AUD 0.02 | — |
| Growth vs a year ago | −100.0% | +0.6% | — |
Revenue estimates
| Total | This quarterDec 2026 | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|---|
| Average estimate | AUD 11.78M | AUD 33.00M | AUD 45.30M |
| Lowest estimate | AUD 11.78M | AUD 33.00M | AUD 45.30M |
| Highest estimate | AUD 11.78M | AUD 33.00M | AUD 45.30M |
| Number of analysts | 1 | 1 | 1 |
| A year ago | AUD 8.86M | AUD 23.88M | — |
| Growth vs a year ago | +32.9% | +38.2% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Biome Australia Limited. Biome Australia Limited has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| EXL.AXElixinol Wellness Limited | Healthcare | Drug Manufacturers - Specialty & Generic | — | ||
| EZZ.AXEZZ Life Science Holdings Limited | Healthcare | Biotechnology | — | ||
| HCT.AXHolista Colltech Limited | Healthcare | Biotechnology | — | ||
| NGS.AXNutritional Growth Solutions Ltd. | Consumer Defensive | Packaged Foods | — | ||
| S66.AXStar Combo Pharma Limited | Consumer Defensive | Household & Personal Products | — | ||
| SKN.AXSkin Elements Limited | Consumer Defensive | Household & Personal Products | — | ||
| VLS.AXVita Life Sciences Limited | Healthcare | Drug Manufacturers - Specialty & Generic | — | ||
| WNX.AXWellnex Life Limited | Consumer Defensive | Packaged Foods | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| FSPMFusionPharm, Inc. | Healthcare | OTC | $1,259 | ||
| GCANThe Greater Cannabis Company, Inc. | Healthcare | OTC | $207,059 | ||
| GEATFRadiko Holdings Corp. | Healthcare | OTC | $4,453 | ||
| GEDSFGedeon Richter PLC | Healthcare | OTC | $4.5B | ||
| GHTIG-H-3 International Inc. | Healthcare | OTC | — | ||
| GRPIGrupo International Inc. | Healthcare | OTC | $1,043 | ||
| GSACGelStat Corporation | Healthcare | OTC | $247,192 | ||
| GWLLGoldenwell Biotech, Inc. | Healthcare | OTC | $104.0M | ||
| HADVHealth Advance Inc. | Healthcare | OTC | $48,284 | ||
| HELPCybin Inc. Common Stock | Healthcare | NASDAQ | $427.1M | ||
| HEWAHealthWarehouse.com, Inc. | Healthcare | OTC | $4.7M | ||
| HITIHigh Tide Inc. | Healthcare | NASDAQ | $211.3M | ||

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Biome Australia Limited.